Myovant Sciences Ltd
Biotechnology
Healthcare
MYOV
96.86 M shares
NYSE US
traded
09 Mar 2023
listed
yes
open
26.99
52 week high
27.02
high
27.00
52 week low
7.78
previous Close
26.99
P/E ratio
market cap
2.63 B
div yield
0
net incoming
-57.63 M
-26.32 %
net profit margin
-57.50 %
-13.00 %
operating incoming
-51.90 M
-53.94 %
net change in cash
-96.07 M
-679.40 %
cash on hand
251 M
-26.72 %
cost of revenue
34.23 M
25.10 %
top